Skip to content
Skip to main menu
Menu
Mobile menu toggle
The Problem
The Blood-Brain Barrier
Brain Cancers
Alzheimer’s Diseases
Parkinson’s Disease
Our Solution
Our Solution
Our Applications
Our Product Map
Our Culture
Our Team
News & Publications
News
Publications
Contact
From Our Newsroom
News
Cordance Medical Receives NIH/NCI SBIR Phase I Grant to Advance Non-Invasive Focused Ultrasound for Brain Tumor Liquid Biopsy in Glioma Models
September 19, 2024
Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership
September 16, 2024
Cordance Medical Announces Triple Patent Grant to Revolutionize Treatment of Brain Diseases with its Innovative NeuroAccess Platform
April 17, 2024
Cordance Medical Announces Agreement with Stanford Medicine’s Airan and Williams Labs for Precision Neuropsychiatry with Ultrasonic Drug Uncaging Technology
December 6, 2023
Cordance Medical Accepted into Prestigious FDA TAP Program for its NeuroAccess Device
December 5, 2023
Cordance Medical’s NeuroAccess Receives FDA Breakthrough Device Designation for Liquid Biopsy in Brain Tumors
October 25, 2023
Cordance Medical Joins BLOODPAC to Enable Blood-Based Liquid Biopsy Tests for Brain Tumor Patients
October 20, 2023
Cordance Medical Licenses Key Intellectual Property from Washington University to Enhance its NeuroAccess™ Platform
September 28, 2023
Noninvasive, ultrasound-based brain biopsy is feasible, safe in people
September 27, 2023
Cordance Medical and EXACT Therapeutics Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain
September 6, 2023
Cordance Medical Welcomes Esteemed Experts Eric Leuthardt, MD, and Hong Chen, PhD, to Advance NeuroAccess Technology for Liquid Biopsy and Drug Delivery in Brain Diseases
June 1, 2023
Cordance Presents Preclinical Data at the International Society for Therapeutic Ultrasound Symposium
April 24, 2023
Cordance Demonstrates Multi-Site Blood-Brain Barrier Openings in Pre-Clinical Study
March 24, 2023
Cordance Medical Successful in Pre-Clinical Studies
January 10, 2023
Cordance Medical Awarded United States Patent for Methods in Opening the Blood-Brain Barrier
January 10, 2023
Cordance Medical technology presented at the Society for Neuro-Oncology Annual Meeting
November 19, 2021
Cordance Medical accepted into Endless Frontier Labs Deep Technology Accelerator
September 24, 2021
Cordance Medical accepted into Creative Destructive Labs Neurology Accelerator
September 17, 2021
Cordance Medical awarded Phase II National Science Foundation Award
July 16, 2021
Cordance Medical appoints Ryan Dittamore as Chief Executive Officer
May 1, 2021
References
Focused Ultrasound Drug Delivery Efficacy References
Focused Ultrasound Safety References